VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 53 filers reported holding VISTAGEN THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,296 | -34.1% | 32,000 | 0.0% | 0.00% | – |
| Q3 2022 | $5,000 | -82.1% | 32,000 | 0.0% | 0.00% | – |
| Q2 2022 | $28,000 | -30.0% | 32,000 | 0.0% | 0.00% | – |
| Q1 2022 | $40,000 | -56.5% | 32,000 | -4.3% | 0.00% | – |
| Q3 2021 | $92,000 | -3.2% | 33,434 | +11.4% | 0.00% | – |
| Q2 2021 | $95,000 | +11.8% | 30,000 | -25.0% | 0.00% | – |
| Q1 2021 | $85,000 | +73.5% | 40,000 | +60.0% | 0.00% | – |
| Q4 2020 | $49,000 | +40.0% | 25,000 | -50.0% | 0.00% | – |
| Q3 2020 | $35,000 | +66.7% | 50,000 | +25.0% | 0.00% | – |
| Q2 2020 | $21,000 | +16.7% | 40,000 | 0.0% | 0.00% | – |
| Q1 2020 | $18,000 | +5.9% | 40,000 | +60.0% | 0.00% | – |
| Q4 2019 | $17,000 | -74.6% | 25,000 | -60.0% | 0.00% | – |
| Q3 2019 | $67,000 | +148.1% | 62,500 | +66.7% | 0.00% | – |
| Q2 2019 | $27,000 | – | 37,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 11,728,033 | $36,943,000 | 14.76% |
| VR Adviser, LLC | 16,047,286 | $50,549,000 | 6.13% |
| COMMODORE CAPITAL LP | 3,331,315 | $10,494,000 | 3.66% |
| Ghost Tree Capital, LLC | 2,000,000 | $6,300,000 | 1.73% |
| EPIQ PARTNERS, LLC | 932,956 | $2,939,000 | 1.47% |
| SPHERA FUNDS MANAGEMENT LTD. | 4,080,673 | $12,854,000 | 0.87% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 615,547 | $1,939,000 | 0.86% |
| HighVista Strategies LLC | 308,096 | $971,000 | 0.69% |
| NEA Management Company, LLC | 16,302,596 | $51,353,000 | 0.67% |
| Nicholas Investment Partners, LP | 2,753,880 | $8,675,000 | 0.54% |